A survey of antimicrobial resistance in a tertiary referral hospital in the United Arab Emirates

Journal of Chemotherapy

Volumn 17, Issue 4, 2005, Pages 376-379

  Jumaa, Pauline A ^a,b   Neringer, R ^a  

^a TAWAM HOSPITAL   (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Antibiogram; Antimicrobial; Empirical therapy; Resistance; Surveillance; Susceptibility; United Arab Emirates

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; OXACILLIN; PENICILLIN G; PIPERACILLIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CAMPYLOBACTER; DRUG SENSITIVITY; ESCHERICHIA COLI; GRAM NEGATIVE ANAEROBIC BACTERIA; HEALTH SURVEY; HOSPITAL; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; SHIGELLA SONNEI; STREPTOCOCCUS PNEUMONIAE; TRAVEL; UNITED ARAB EMIRATES;

EID: 24644457010     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.4.376     Document Type: Article

References (23)

1. WHO Global Strategy for Containment of Antimicrobial Resistance. WHO Geneva 2001.
2. Felmingham D, Gruneberg RN and the Alexander Project Group. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000; 45: 191-203.
3. Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN and the Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52: 229-246.
4. WHO 1996. Guidelines for Antimicrobial Resistance Surveillance. WHO Regional Office for the Eastern Mediterranean, Alexandria, Egypt.
5. Fridkin SK, Edwards JR, Tenover FC, Gaynes RP, McGowan JE Jr. Antimicrobial resistance rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis 2001; 33: 324-30.
6. National Committee for Clinical laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing. Villanova, PA: NCCLS 2000.
7. National Committee for Clinical laboratory Standards (NCCLS). Performance standards for Antimicrobial Susceptibility Testing. Villanova, PA: NCCLS 2002-M100-S12.
8. Epi Info Version 6.02: a word processing and statistics programme for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, Georgia, USA 1994.
9. WHONET 5 1999. World Health Organization Geneva Switzerland and WHO Collaborating Center for Surveillance of Antimicrobial Resistance Boston MA USA. Available from: URL: http://www.who.int/csr/drugresist/whonetsoftware/ en/index.html
10. Damjanovic V, Furtado M, Patmore M. Antibiotic sensitivity of enteropathogenic bacteria isolated from patients in a Sharjah hospital. J Hyg (Lond) 1984; 92: 205-8.
11. Al Hittawi K, Ison CA. Characteristics of gonococci isolated from men with urethritis in Dubai. Epidemiol Infect 1996; 116: 15-20.
12. Trad O, Jumaa PA, Afify Z. The changing pattern of bloodstream infection in pediatric oncology patients in the United Arab Emirates. Pediatr Hematol Oncol 2003; 20: 281-9.
13. Walther SM, Erlandsson M, Burman LG et al. Antibiotic prescription practices, consumption and bacterial resistance in a cross-section of Swedish intensive care units. Acta Anaesthesiol Scand 2002; 46: 1075-1081.
14. Diekema DJ, Pfaller MA, Jones RN, The SENTRY participants group. Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America SENTRY antimicrobial Surveillance Program 1997-2000. Int J Antimicrob Agents 2002; 20: 412-8.
15. Mutnick AH, Biedenbach DJ, Jones RN. Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diag Microbiol Infect Dis 2003; 46: 63-68.
16. Al Aqeeli AA, Guy ML, Al-Jumaah SA. Streptococcus pneumoniae resistance in a tertiary care center in Saudi Arabia. Saudi Med J 2002; 23: 400-404.
17. Song JH, Jung SI, Ko KS, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP Study). Antimicrob Agents Chemother 2004; 48: 2101-2107.
18. Al Jasser AM, Elkhizzi HA. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa Saudi Med J 2004; 25: 780-784.
19. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program(1997-2002) Diagn Microbiol Infect Dis 2004; 50: 59-69.
20. Gupta A, Nelson JM, Barrett TJ, et al and NARMS Working Group. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg Infect Dis 2004; 10: 1102-1109.
21. Putnam SD, Riddle MS, Wierzba TF, Pittner BT, Elyazeed, El-Gendy A et al. Antimicrobial susceptibility trends among Escherichia coli and Shigella spp. isolated from rural Egyptian paediatric populations with diarrhoea between 1995 and 2000. Clin Microbiol Infect 2004; 10: 804-810.
22. Richet HM, Mohammed J, McDonald LC, Jarvis WR and INSPEAR. Building Communication Networks: International Network for the Study and Prevention of Emerging Antimicrobial Resistance. Emerg Infect Dis 2001; 7: 319-322.
23. th International Congress for Infectious Diseases, Singapore, 11-14 March 2002. Abstract 11.003.